GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Take Ltd

TAKE Ltd Q2 FY27 Consolidated Net Profit ₹22.12 Million, Returns to Profitability

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 13 Nov 2026, 06:42 PM IST  ·  BSE ID: 18d8de20-45ae-4803-8e4e-b40659a8d270
View Original BSE Filing (PDF)
💡
In Simple Terms
The company returned to profit this quarter, earning ₹22.12 Million, driven by growth in its digital and healthcare businesses.
🤖 AI Summary
  • TAKE Ltd reported consolidated net profit of ₹22.12 Million for Q2 FY27, a return to profitability.
  • Half-year consolidated total income reached ₹615.54 Million, with consolidated PAT at ₹32.75 Million.
  • Standalone total income for Q2 FY27 was ₹1,475.54 Lakhs, showing quarter-on-quarter growth.
  • Standalone net profit for Q2 FY27 stood at ₹222.09 Lakhs, registering 129.36% QoQ growth.
  • The company launched TAKE.Heal, an AI-driven digital health platform, and a ₹5 Crore innovation fund.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Consolidated Total Income (Half Year ended Sep 30, 2026)
₹615.54 Million
Consolidated PAT (Half Year ended Sep 30, 2026)
₹32.75 Million
Not comparable — limited prior period data.
Standalone Total Income (Quarter ended Sep 30, 2026)
₹1,475.54 Lakhs
Standalone Net Profit (Quarter ended Sep 30, 2026)
₹222.09 Lakhs
Consolidated Net Profit (Quarter ended Sep 30, 2026)
₹22.12 Million
108.17% QoQ growth over ₹10.63 Million in Q1 FY27
🏢 How This Affects the Company
📈
Business Impact
The company's focus on digital healthcare, AI, and emerging wellness opportunities, including the launch of TAKE.Heal, indicates a strategic shift towards innovation-led growth. The establishment of a ₹5 Crore innovation fund aims to support high-potential startups in these areas.
💰
Financial Impact
TAKE Ltd returned to profitability on both a standalone and consolidated basis, with Q2 FY27 consolidated net profit at ₹22.12 Million and half-year consolidated PAT at ₹32.75 Million. This contrasts with losses in the prior year's corresponding period.
⚙️
Operational Impact
The launch of TAKE.Heal, an intelligent digital health platform, and entry into India's longevity and anti-aging market with science-backed solutions, signifies new operational ventures and product development.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's return to profitability and strategic direction, as demonstrated by the consolidated PAT of ₹32.75 Million for H1 FY27.
🔍
Management Signal
Management's decision to focus on innovation in healthcare, AI, and wellness, coupled with the return to profitability, signals a clear strategic shift and disciplined execution.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — check sustainability of profitability and growth.
Updates on TAKE.Heal platform adoption and innovation fund investments.
Progress reports on expansion into India's longevity and anti-aging market.
LOW RISK The filing indicates a return to profitability and strategic clarity, reducing immediate financial risk indicators.
💡 Investor Takeaway
TAKE Ltd reported consolidated net profit of ₹22.12 Million for Q2 FY27, returning to profitability from a loss of ₹2.31 Million in H1 FY26. Half-year consolidated total income was ₹615.54 Million, with PAT at ₹32.75 Million. Standalone net profit for Q2 FY27 grew 129.36% QoQ to ₹222.09 Lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Q2 FY27 consolidated net profit reached ₹22.12 Million, reflecting a return to profitability from a loss of ₹2.31 Million in H1 FY26.
  • Standalone net profit for Q2 FY27 increased to ₹222.09 Lakhs, demonstrating 129.36% quarter-on-quarter growth.

⚠️ Concerns

  • Standalone Revenue from Operations for Q2 FY27 stood at ₹1,431.98 Lakhs, with no corresponding prior year data for comparison.
  • Half-year consolidated total income of ₹615.54 Million is noted as 'notable transition' compared to the corresponding period of the previous year.
📅 Company Track Record
Previous filings for TAKE Ltd (BSE: 532890) show a press release on November 13, 2026, highlighting H1 FY27 consolidated PAT of ₹32.75 Million and a return to profitability. The current results align with this positive trend.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was TAKE Ltd's consolidated net profit in Q2 FY27?
TAKE Ltd reported a consolidated net profit of ₹22.12 Million for the quarter ended September 30, 2026 (Q2 FY27).
What was TAKE Ltd's half-year consolidated PAT for FY27?
For the half year ended September 30, 2026 (H1 FY27), TAKE Ltd recorded a consolidated PAT of ₹32.75 Million.
How did TAKE Ltd's standalone net profit perform in Q2 FY27?
TAKE Ltd's standalone net profit for Q2 FY27 increased to ₹222.09 Lakhs, registering a 129.36% quarter-on-quarter growth compared to ₹96.83 Lakhs in the preceding quarter.
What new initiatives has TAKE Ltd announced in Q2 FY27?
TAKE Ltd announced the launch of TAKE.Heal, an intelligent digital health platform, and a ₹5 Crore innovation fund to support high-potential startups in AI, deep technology, and digital health.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.